

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | prenylation (GO:0097354) | 6.20022957 |
| 2 | protein prenylation (GO:0018342) | 6.20022957 |
| 3 | fucose catabolic process (GO:0019317) | 5.14287991 |
| 4 | L-fucose metabolic process (GO:0042354) | 5.14287991 |
| 5 | L-fucose catabolic process (GO:0042355) | 5.14287991 |
| 6 | regulation of triglyceride catabolic process (GO:0010896) | 5.07629457 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.00366550 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.00366550 |
| 9 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.67812218 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.66441927 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 4.62086002 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.62086002 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.24579921 |
| 14 | preassembly of GPI anchor in ER membrane (GO:0016254) | 4.11530549 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.06934506 |
| 16 | indolalkylamine metabolic process (GO:0006586) | 4.06913793 |
| 17 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 4.01589498 |
| 18 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 4.01589498 |
| 19 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 4.01589498 |
| 20 | cell wall macromolecule metabolic process (GO:0044036) | 3.94719163 |
| 21 | cell wall macromolecule catabolic process (GO:0016998) | 3.94719163 |
| 22 | urea cycle (GO:0000050) | 3.91953005 |
| 23 | urea metabolic process (GO:0019627) | 3.91953005 |
| 24 | behavioral response to nicotine (GO:0035095) | 3.89689061 |
| 25 | bile acid biosynthetic process (GO:0006699) | 3.72571103 |
| 26 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.70960909 |
| 27 | detection of light stimulus involved in visual perception (GO:0050908) | 3.63453789 |
| 28 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.63453789 |
| 29 | complement activation, alternative pathway (GO:0006957) | 3.63368202 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 3.61535183 |
| 31 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.58784769 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 3.53892476 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 3.52695910 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 3.52695910 |
| 35 | tryptophan catabolic process (GO:0006569) | 3.52695910 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.52294320 |
| 37 | protein carboxylation (GO:0018214) | 3.48128416 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.48128416 |
| 39 | retinal cone cell development (GO:0046549) | 3.46642198 |
| 40 | neural tube formation (GO:0001841) | 3.44504919 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.42609009 |
| 42 | cysteine metabolic process (GO:0006534) | 3.41649852 |
| 43 | bile acid metabolic process (GO:0008206) | 3.33701995 |
| 44 | lysine catabolic process (GO:0006554) | 3.32779634 |
| 45 | lysine metabolic process (GO:0006553) | 3.32779634 |
| 46 | epithelial cilium movement (GO:0003351) | 3.31033022 |
| 47 | regulation of fibrinolysis (GO:0051917) | 3.30453329 |
| 48 | cellular extravasation (GO:0045123) | 3.29272506 |
| 49 | negative regulation of mast cell activation (GO:0033004) | 3.26421562 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 3.25861394 |
| 51 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.25665520 |
| 52 | photoreceptor cell maintenance (GO:0045494) | 3.23382054 |
| 53 | piRNA metabolic process (GO:0034587) | 3.20540585 |
| 54 | regulation of protein activation cascade (GO:2000257) | 3.18636494 |
| 55 | neuron remodeling (GO:0016322) | 3.18161131 |
| 56 | response to pheromone (GO:0019236) | 3.17965941 |
| 57 | GPI anchor metabolic process (GO:0006505) | 3.16713023 |
| 58 | negative regulation of sterol transport (GO:0032372) | 3.14797461 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.14797461 |
| 60 | cilium morphogenesis (GO:0060271) | 3.14054940 |
| 61 | behavioral response to ethanol (GO:0048149) | 3.13749211 |
| 62 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.13583665 |
| 63 | seminiferous tubule development (GO:0072520) | 3.12737028 |
| 64 | axoneme assembly (GO:0035082) | 3.12406993 |
| 65 | high-density lipoprotein particle remodeling (GO:0034375) | 3.10345562 |
| 66 | tryptophan metabolic process (GO:0006568) | 3.08319116 |
| 67 | coenzyme catabolic process (GO:0009109) | 3.07818457 |
| 68 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.06324272 |
| 69 | indole-containing compound metabolic process (GO:0042430) | 3.02036439 |
| 70 | mast cell degranulation (GO:0043303) | 3.01828174 |
| 71 | mast cell activation involved in immune response (GO:0002279) | 3.01828174 |
| 72 | C-terminal protein lipidation (GO:0006501) | 3.00429110 |
| 73 | glutamate metabolic process (GO:0006536) | 2.99750283 |
| 74 | triglyceride homeostasis (GO:0070328) | 2.98947420 |
| 75 | acylglycerol homeostasis (GO:0055090) | 2.98947420 |
| 76 | eosinophil chemotaxis (GO:0048245) | 2.98721879 |
| 77 | cornea development in camera-type eye (GO:0061303) | 2.98309795 |
| 78 | platelet dense granule organization (GO:0060155) | 2.97620406 |
| 79 | regulation of complement activation (GO:0030449) | 2.97310673 |
| 80 | very long-chain fatty acid metabolic process (GO:0000038) | 2.96626347 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 2.95760824 |
| 82 | protein K11-linked deubiquitination (GO:0035871) | 2.94257701 |
| 83 | regulation of cilium movement (GO:0003352) | 2.92964355 |
| 84 | acrosome assembly (GO:0001675) | 2.91479082 |
| 85 | sulfur amino acid catabolic process (GO:0000098) | 2.90878653 |
| 86 | nonmotile primary cilium assembly (GO:0035058) | 2.90821463 |
| 87 | primary alcohol catabolic process (GO:0034310) | 2.89153502 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 2.87719659 |
| 89 | cilium movement (GO:0003341) | 2.86218641 |
| 90 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.86030874 |
| 91 | regulation of triglyceride metabolic process (GO:0090207) | 2.85879364 |
| 92 | amine catabolic process (GO:0009310) | 2.85787674 |
| 93 | cellular biogenic amine catabolic process (GO:0042402) | 2.85787674 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 2.84407112 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 2.84188283 |
| 96 | replication fork processing (GO:0031297) | 2.83878695 |
| 97 | adaptation of signaling pathway (GO:0023058) | 2.83517614 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.82347748 |
| 99 | protein-lipid complex remodeling (GO:0034368) | 2.82046227 |
| 100 | macromolecular complex remodeling (GO:0034367) | 2.82046227 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 2.82046227 |
| 102 | C-terminal protein amino acid modification (GO:0018410) | 2.81786865 |
| 103 | negative regulation of Ras GTPase activity (GO:0034261) | 2.81781098 |
| 104 | amyloid precursor protein catabolic process (GO:0042987) | 2.81769678 |
| 105 | recombinational repair (GO:0000725) | 2.81384765 |
| 106 | double-strand break repair via homologous recombination (GO:0000724) | 2.80718954 |
| 107 | homocysteine metabolic process (GO:0050667) | 2.80570501 |
| 108 | linoleic acid metabolic process (GO:0043651) | 2.80516884 |
| 109 | regulation of cholesterol homeostasis (GO:2000188) | 2.80396094 |
| 110 | activated T cell proliferation (GO:0050798) | 2.80311529 |
| 111 | cellular modified amino acid catabolic process (GO:0042219) | 2.78109192 |
| 112 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.77400175 |
| 113 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77310113 |
| 114 | ethanol metabolic process (GO:0006067) | 2.77149741 |
| 115 | protein polyglutamylation (GO:0018095) | 2.76536807 |
| 116 | dopamine transport (GO:0015872) | 2.76420455 |
| 117 | DNA double-strand break processing (GO:0000729) | 2.76376075 |
| 118 | intraciliary transport (GO:0042073) | 2.75958865 |
| 119 | aldehyde catabolic process (GO:0046185) | 2.75936671 |
| 120 | gamma-aminobutyric acid transport (GO:0015812) | 2.75211483 |
| 121 | cofactor catabolic process (GO:0051187) | 2.74856985 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 2.74726914 |
| 123 | photoreceptor cell development (GO:0042461) | 2.73672427 |
| 124 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.73130604 |
| 125 | cilium organization (GO:0044782) | 2.71408328 |
| 126 | amino-acid betaine metabolic process (GO:0006577) | 2.70260531 |
| 127 | proteasome assembly (GO:0043248) | 2.69930167 |
| 128 | protein import into peroxisome matrix (GO:0016558) | 2.69683426 |
| 129 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.69531210 |
| 130 | serine family amino acid catabolic process (GO:0009071) | 2.69470193 |
| 131 | eosinophil migration (GO:0072677) | 2.69358052 |
| 132 | DNA demethylation (GO:0080111) | 2.68966070 |
| 133 | tachykinin receptor signaling pathway (GO:0007217) | 2.68537283 |
| 134 | cellular amino acid catabolic process (GO:0009063) | 2.68270878 |
| 135 | fatty acid oxidation (GO:0019395) | 2.67769623 |
| 136 | aromatic amino acid family metabolic process (GO:0009072) | 2.67731494 |
| 137 | reverse cholesterol transport (GO:0043691) | 2.67542532 |
| 138 | lipid oxidation (GO:0034440) | 2.67089821 |
| 139 | nucleobase catabolic process (GO:0046113) | 2.66762399 |
| 140 | protein localization to cilium (GO:0061512) | 2.66501931 |
| 141 | positive regulation of calcium ion import (GO:0090280) | 2.65501571 |
| 142 | phospholipid efflux (GO:0033700) | 2.64963215 |
| 143 | GPI anchor biosynthetic process (GO:0006506) | 2.64903090 |
| 144 | fatty acid beta-oxidation (GO:0006635) | 2.64136437 |
| 145 | ketone body metabolic process (GO:1902224) | 2.63797257 |
| 146 | cilium assembly (GO:0042384) | 2.63520085 |
| 147 | DNA integration (GO:0015074) | 2.63075732 |
| 148 | auditory receptor cell stereocilium organization (GO:0060088) | 2.62330549 |
| 149 | DNA deamination (GO:0045006) | 2.61421956 |
| 150 | cellular ketone body metabolic process (GO:0046950) | 2.61031979 |
| 151 | cholesterol efflux (GO:0033344) | 2.61011987 |
| 152 | reflex (GO:0060004) | 2.60679005 |
| 153 | response to mercury ion (GO:0046689) | 2.60586361 |
| 154 | multicellular organism reproduction (GO:0032504) | 2.60168067 |
| 155 | glycolipid biosynthetic process (GO:0009247) | 2.60130089 |
| 156 | ethanol oxidation (GO:0006069) | 2.59835944 |
| 157 | response to methylmercury (GO:0051597) | 2.59313963 |
| 158 | regulation of lipid catabolic process (GO:0050994) | 2.58887357 |
| 159 | bile acid and bile salt transport (GO:0015721) | 2.58739820 |
| 160 | drug catabolic process (GO:0042737) | 2.58616438 |
| 161 | negative regulation of lipid catabolic process (GO:0050995) | 2.58437366 |
| 162 | oxidative demethylation (GO:0070989) | 2.57598184 |
| 163 | negative regulation of lipase activity (GO:0060192) | 2.54686111 |
| 164 | cellular glucuronidation (GO:0052695) | 2.54674538 |
| 165 | inner ear receptor stereocilium organization (GO:0060122) | 2.53244542 |
| 166 | fatty acid catabolic process (GO:0009062) | 2.52752644 |
| 167 | DNA methylation involved in gamete generation (GO:0043046) | 2.52663165 |
| 168 | fibrinolysis (GO:0042730) | 2.52360632 |
| 169 | cholesterol homeostasis (GO:0042632) | 2.51270247 |
| 170 | regulation of meiosis I (GO:0060631) | 2.51044056 |
| 171 | pantothenate metabolic process (GO:0015939) | 2.50726676 |
| 172 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.50720791 |
| 173 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.50666621 |
| 174 | glycosphingolipid biosynthetic process (GO:0006688) | 2.50385637 |
| 175 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.49420671 |
| 176 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.49263693 |
| 177 | sterol homeostasis (GO:0055092) | 2.48539248 |
| 178 | eye photoreceptor cell development (GO:0042462) | 2.48411604 |
| 179 | drug transmembrane transport (GO:0006855) | 2.48386651 |
| 180 | protein-lipid complex assembly (GO:0065005) | 2.48283414 |
| 181 | low-density lipoprotein particle remodeling (GO:0034374) | 2.47685505 |
| 182 | complement activation, classical pathway (GO:0006958) | 2.45282858 |
| 183 | presynaptic membrane assembly (GO:0097105) | 2.45000507 |
| 184 | opsonization (GO:0008228) | 2.44148825 |
| 185 | growth hormone receptor signaling pathway (GO:0060396) | 2.43608564 |
| 186 | proline transport (GO:0015824) | 2.43495639 |
| 187 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.43302985 |
| 188 | respiratory chain complex IV assembly (GO:0008535) | 2.42912814 |
| 189 | serotonin metabolic process (GO:0042428) | 2.41585073 |
| 190 | rhodopsin mediated signaling pathway (GO:0016056) | 2.41322991 |
| 191 | fucosylation (GO:0036065) | 2.40449436 |
| 192 | establishment of protein localization to Golgi (GO:0072600) | 2.40130890 |
| 193 | vesicle fusion (GO:0006906) | 2.38065525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.90265778 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.71502976 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.65759207 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.44540120 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.28351403 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.12492958 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.86778826 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.73455001 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.71886282 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.61381100 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.54186577 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.42799046 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.36750425 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.33124980 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.26023359 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15848075 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.01134107 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00766645 |
| 19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.98608081 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.97895565 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.94754628 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.90715436 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90563052 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87084889 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82096886 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.81131102 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74532790 |
| 28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.71190184 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68466263 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68193891 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66529252 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65339691 |
| 33 | STAT3_23295773_ChIP-Seq_U87_Human | 1.62285308 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.60218702 |
| 35 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.59594975 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.58824690 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.58824690 |
| 38 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.57704301 |
| 39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57704301 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57383850 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55946569 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55327986 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54846700 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.54774247 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53654124 |
| 46 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.49820960 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.48769913 |
| 48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46990483 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46599708 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46305852 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46194911 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.45881639 |
| 53 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43752480 |
| 54 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.42750080 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40650365 |
| 56 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.40434108 |
| 57 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39560641 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39197295 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36687120 |
| 60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.35688952 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34935822 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34267454 |
| 63 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.33617098 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32165838 |
| 65 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.31987854 |
| 66 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30493062 |
| 67 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30493062 |
| 68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.28591818 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28230640 |
| 70 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27408389 |
| 71 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27164198 |
| 72 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24505502 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24474462 |
| 74 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24266890 |
| 75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24185469 |
| 76 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24031981 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22911419 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21904412 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21101753 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20424624 |
| 81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17621307 |
| 82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17417445 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16648168 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16067451 |
| 85 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15064144 |
| 86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14271993 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12834884 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12834884 |
| 89 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12800610 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12123758 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11204591 |
| 92 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10894468 |
| 93 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10556911 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09894063 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08430155 |
| 96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08288932 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07619186 |
| 98 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06351908 |
| 99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06046171 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05311296 |
| 101 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04922032 |
| 102 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04757903 |
| 103 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04619921 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04195294 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03463891 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03134867 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02992373 |
| 108 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02947734 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02879669 |
| 110 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01972660 |
| 111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01926932 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01292959 |
| 113 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00856630 |
| 114 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.99756359 |
| 115 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99386835 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98288186 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98200123 |
| 118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97001923 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96990966 |
| 120 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96886772 |
| 121 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96389753 |
| 122 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96268535 |
| 123 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95135254 |
| 124 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93754725 |
| 125 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.92930509 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92360286 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91990931 |
| 128 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91309059 |
| 129 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89889972 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89169770 |
| 131 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89052229 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88803676 |
| 133 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88608809 |
| 134 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88230947 |
| 135 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87778452 |
| 136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87660779 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87496560 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87469542 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87153768 |
| 140 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86265467 |
| 141 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85186052 |
| 142 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84935671 |
| 143 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84541313 |
| 144 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82961347 |
| 145 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.82420245 |
| 146 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82170496 |
| 147 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.81807249 |
| 148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81794973 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81794973 |
| 150 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81243138 |
| 151 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77453132 |
| 152 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.77012786 |
| 153 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76228440 |
| 154 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.75932015 |
| 155 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75837511 |
| 156 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75491745 |
| 157 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75204238 |
| 158 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.75055118 |
| 159 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.74294907 |
| 160 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.74294907 |
| 161 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74017249 |
| 162 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73925882 |
| 163 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73670601 |
| 164 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.73168854 |
| 165 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.72545865 |
| 166 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.72391472 |
| 167 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.71852589 |
| 168 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.71769556 |
| 169 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71710265 |
| 170 | P300_19829295_ChIP-Seq_ESCs_Human | 0.71584612 |
| 171 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.71432639 |
| 172 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.70337694 |
| 173 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69944577 |
| 174 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.69712502 |
| 175 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.69487571 |
| 176 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.69317159 |
| 177 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.69115790 |
| 178 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69078178 |
| 179 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.69065778 |
| 180 | TP53_16413492_ChIP-PET_HCT116_Human | 0.67994290 |
| 181 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.67649397 |
| 182 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66747964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.29326440 |
| 2 | MP0005360_urolithiasis | 5.22360372 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.38879000 |
| 4 | MP0005365_abnormal_bile_salt | 4.21090677 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.57988595 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.48300774 |
| 7 | MP0002102_abnormal_ear_morphology | 3.21305631 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.86993173 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.83549336 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.80737937 |
| 11 | MP0009840_abnormal_foam_cell | 2.50522570 |
| 12 | MP0003252_abnormal_bile_duct | 2.49408883 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.45015403 |
| 14 | MP0005410_abnormal_fertilization | 2.36595759 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.30338226 |
| 16 | MP0000604_amyloidosis | 2.27795955 |
| 17 | MP0005083_abnormal_biliary_tract | 2.27016185 |
| 18 | MP0003303_peritoneal_inflammation | 2.25838061 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 2.23945494 |
| 20 | MP0003690_abnormal_glial_cell | 2.23274890 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.14849059 |
| 22 | MP0005332_abnormal_amino_acid | 2.12244264 |
| 23 | MP0005253_abnormal_eye_physiology | 2.07744963 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.06359952 |
| 25 | MP0003329_amyloid_beta_deposits | 2.05792590 |
| 26 | MP0000427_abnormal_hair_cycle | 1.99797214 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.97253037 |
| 28 | MP0009046_muscle_twitch | 1.96207600 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.93130176 |
| 30 | MP0003195_calcinosis | 1.89111291 |
| 31 | MP0001984_abnormal_olfaction | 1.87066899 |
| 32 | MP0003787_abnormal_imprinting | 1.86929762 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.86218718 |
| 34 | MP0001919_abnormal_reproductive_system | 1.85339578 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.83975686 |
| 36 | MP0003880_abnormal_central_pattern | 1.83904237 |
| 37 | MP0000566_synostosis | 1.82174293 |
| 38 | MP0002736_abnormal_nociception_after | 1.80508682 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.80248635 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.77846778 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.74386136 |
| 42 | MP0000920_abnormal_myelination | 1.71476147 |
| 43 | MP0009745_abnormal_behavioral_response | 1.70690456 |
| 44 | MP0001486_abnormal_startle_reflex | 1.70578004 |
| 45 | MP0000383_abnormal_hair_follicle | 1.68979935 |
| 46 | MP0003868_abnormal_feces_composition | 1.68978286 |
| 47 | MP0000609_abnormal_liver_physiology | 1.64421249 |
| 48 | MP0004130_abnormal_muscle_cell | 1.63135774 |
| 49 | MP0003436_decreased_susceptibility_to | 1.59648414 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.59265992 |
| 51 | MP0005389_reproductive_system_phenotype | 1.58131571 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.57877284 |
| 53 | MP0001529_abnormal_vocalization | 1.57620726 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.57059532 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.55955067 |
| 56 | MP0008058_abnormal_DNA_repair | 1.55728048 |
| 57 | MP0005171_absent_coat_pigmentation | 1.55549794 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.55517543 |
| 59 | MP0005387_immune_system_phenotype | 1.54506995 |
| 60 | MP0001790_abnormal_immune_system | 1.54506995 |
| 61 | MP0008872_abnormal_physiological_respon | 1.50394652 |
| 62 | MP0004510_myositis | 1.50005246 |
| 63 | MP0002751_abnormal_autonomic_nervous | 1.49930202 |
| 64 | MP0001764_abnormal_homeostasis | 1.45846135 |
| 65 | MP0002272_abnormal_nervous_system | 1.43656648 |
| 66 | MP0004019_abnormal_vitamin_homeostasis | 1.42966285 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41784862 |
| 68 | MP0004147_increased_porphyrin_level | 1.41379095 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.40275856 |
| 70 | MP0003646_muscle_fatigue | 1.40145678 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.36974101 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.35954817 |
| 73 | MP0003718_maternal_effect | 1.35667674 |
| 74 | MP0004142_abnormal_muscle_tone | 1.35420634 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.34305194 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.33668965 |
| 77 | MP0001800_abnormal_humoral_immune | 1.28539043 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 1.27397760 |
| 79 | MP0002735_abnormal_chemical_nociception | 1.26381682 |
| 80 | MP0002419_abnormal_innate_immunity | 1.26081656 |
| 81 | MP0002938_white_spotting | 1.25731781 |
| 82 | MP0002653_abnormal_ependyma_morphology | 1.25383311 |
| 83 | MP0004043_abnormal_pH_regulation | 1.23214480 |
| 84 | MP0004742_abnormal_vestibular_system | 1.20968457 |
| 85 | MP0005535_abnormal_body_temperature | 1.20671073 |
| 86 | MP0001835_abnormal_antigen_presentation | 1.19376227 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 1.19122686 |
| 88 | MP0006054_spinal_hemorrhage | 1.19033858 |
| 89 | MP0003136_yellow_coat_color | 1.16025700 |
| 90 | MP0001664_abnormal_digestion | 1.15882175 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 1.15815681 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 1.14351876 |
| 93 | MP0008961_abnormal_basal_metabolism | 1.14239102 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 1.14104796 |
| 95 | MP0004885_abnormal_endolymph | 1.12065896 |
| 96 | MP0005000_abnormal_immune_tolerance | 1.12027945 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 1.11100477 |
| 98 | MP0001970_abnormal_pain_threshold | 1.11026187 |
| 99 | MP0010678_abnormal_skin_adnexa | 1.10274658 |
| 100 | MP0003075_altered_response_to | 1.09691890 |
| 101 | MP0002452_abnormal_antigen_presenting | 1.09120678 |
| 102 | MP0004215_abnormal_myocardial_fiber | 1.08606101 |
| 103 | MP0009643_abnormal_urine_homeostasis | 1.08201799 |
| 104 | MP0001765_abnormal_ion_homeostasis | 1.08132535 |
| 105 | MP0008469_abnormal_protein_level | 1.07392350 |
| 106 | MP0004924_abnormal_behavior | 1.06946877 |
| 107 | MP0005386_behavior/neurological_phenoty | 1.06946877 |
| 108 | MP0002160_abnormal_reproductive_system | 1.05882303 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 1.05830610 |
| 110 | MP0002557_abnormal_social/conspecific_i | 1.05579592 |
| 111 | MP0005025_abnormal_response_to | 1.02955897 |
| 112 | MP0002163_abnormal_gland_morphology | 1.01643943 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 1.01395102 |
| 114 | MP0009763_increased_sensitivity_to | 1.00415090 |
| 115 | MP0002928_abnormal_bile_duct | 0.99537663 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.98774078 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.98694237 |
| 118 | MP0002067_abnormal_sensory_capabilities | 0.98614695 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.97348086 |
| 120 | MP0002723_abnormal_immune_serum | 0.97284502 |
| 121 | MP0002064_seizures | 0.96162158 |
| 122 | MP0001440_abnormal_grooming_behavior | 0.95692238 |
| 123 | MP0002971_abnormal_brown_adipose | 0.94783075 |
| 124 | MP0005195_abnormal_posterior_eye | 0.94620744 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.94141399 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.94062774 |
| 127 | MP0005166_decreased_susceptibility_to | 0.91799615 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.91637555 |
| 129 | MP0005451_abnormal_body_composition | 0.91613927 |
| 130 | MP0003937_abnormal_limbs/digits/tail_de | 0.91099753 |
| 131 | MP0001324_abnormal_eye_pigmentation | 0.91037488 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.90671168 |
| 133 | MP0000778_abnormal_nervous_system | 0.90596110 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.90337881 |
| 135 | MP0008995_early_reproductive_senescence | 0.89145274 |
| 136 | MP0002234_abnormal_pharynx_morphology | 0.89112834 |
| 137 | MP0003635_abnormal_synaptic_transmissio | 0.88632708 |
| 138 | MP0008874_decreased_physiological_sensi | 0.88455506 |
| 139 | MP0006082_CNS_inflammation | 0.87687192 |
| 140 | MP0004484_altered_response_of | 0.87156672 |
| 141 | MP0003633_abnormal_nervous_system | 0.86390955 |
| 142 | MP0001963_abnormal_hearing_physiology | 0.86298552 |
| 143 | MP0003011_delayed_dark_adaptation | 0.86243105 |
| 144 | MP0000685_abnormal_immune_system | 0.85957633 |
| 145 | MP0002229_neurodegeneration | 0.84525148 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.84466330 |
| 147 | MP0000026_abnormal_inner_ear | 0.84011316 |
| 148 | MP0003121_genomic_imprinting | 0.83661401 |
| 149 | MP0003698_abnormal_male_reproductive | 0.83126044 |
| 150 | MP0003634_abnormal_glial_cell | 0.82504196 |
| 151 | MP0001929_abnormal_gametogenesis | 0.81710550 |
| 152 | MP0002090_abnormal_vision | 0.81124854 |
| 153 | MP0005367_renal/urinary_system_phenotyp | 0.81112147 |
| 154 | MP0000516_abnormal_urinary_system | 0.81112147 |
| 155 | MP0004133_heterotaxia | 0.80914538 |
| 156 | MP0002420_abnormal_adaptive_immunity | 0.80289125 |
| 157 | MP0001819_abnormal_immune_cell | 0.79528311 |
| 158 | MP0002136_abnormal_kidney_physiology | 0.79469773 |
| 159 | MP0000598_abnormal_liver_morphology | 0.79390906 |
| 160 | MP0005670_abnormal_white_adipose | 0.77078347 |
| 161 | MP0003950_abnormal_plasma_membrane | 0.76503459 |
| 162 | MP0010368_abnormal_lymphatic_system | 0.75027384 |
| 163 | MP0003045_fibrosis | 0.74811327 |
| 164 | MP0005310_abnormal_salivary_gland | 0.73112794 |
| 165 | MP0003724_increased_susceptibility_to | 0.73025785 |
| 166 | MP0001881_abnormal_mammary_gland | 0.72767975 |
| 167 | MP0003183_abnormal_peptide_metabolism | 0.72524969 |
| 168 | MP0005647_abnormal_sex_gland | 0.72322364 |
| 169 | MP0005334_abnormal_fat_pad | 0.70972041 |
| 170 | MP0001501_abnormal_sleep_pattern | 0.70916472 |
| 171 | MP0009764_decreased_sensitivity_to | 0.70886734 |
| 172 | MP0004947_skin_inflammation | 0.70762650 |
| 173 | MP0003631_nervous_system_phenotype | 0.68252718 |
| 174 | MP0005167_abnormal_blood-brain_barrier | 0.68096164 |
| 175 | MP0009642_abnormal_blood_homeostasis | 0.67627302 |
| 176 | MP0004859_abnormal_synaptic_plasticity | 0.66800521 |
| 177 | MP0004134_abnormal_chest_morphology | 0.64691596 |
| 178 | MP0002254_reproductive_system_inflammat | 0.62026178 |
| 179 | MP0002572_abnormal_emotion/affect_behav | 0.60954794 |
| 180 | MP0009785_altered_susceptibility_to | 0.60761530 |
| 181 | MP0002909_abnormal_adrenal_gland | 0.59497055 |
| 182 | MP0001958_emphysema | 0.59206447 |
| 183 | MP0003632_abnormal_nervous_system | 0.58570859 |
| 184 | MP0000343_altered_response_to | 0.57996495 |
| 185 | MP0009765_abnormal_xenobiotic_induced | 0.57878312 |
| 186 | MP0002078_abnormal_glucose_homeostasis | 0.57451853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.13767741 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.82488296 |
| 3 | Xanthomatosis (HP:0000991) | 4.52137013 |
| 4 | Pancreatic cysts (HP:0001737) | 4.31795112 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.31538552 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.07807676 |
| 7 | Pancreatic fibrosis (HP:0100732) | 4.03965805 |
| 8 | Complement deficiency (HP:0004431) | 4.02589383 |
| 9 | Joint hemorrhage (HP:0005261) | 3.91136177 |
| 10 | True hermaphroditism (HP:0010459) | 3.89191804 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.83402551 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.83402551 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.81992250 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.75419299 |
| 15 | Nephronophthisis (HP:0000090) | 3.55696527 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.43018231 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 3.37245992 |
| 18 | Medial flaring of the eyebrow (HP:0010747) | 3.32676567 |
| 19 | Abnormality of the renal cortex (HP:0011035) | 3.26839407 |
| 20 | Epidermoid cyst (HP:0200040) | 3.26516396 |
| 21 | Hyperventilation (HP:0002883) | 3.25907925 |
| 22 | Abnormality of complement system (HP:0005339) | 3.25723565 |
| 23 | Large for gestational age (HP:0001520) | 3.25670878 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.21200270 |
| 25 | Abnormality of the renal medulla (HP:0100957) | 3.18351206 |
| 26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.16927670 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 3.13257809 |
| 28 | Chronic hepatic failure (HP:0100626) | 3.08027014 |
| 29 | Ketosis (HP:0001946) | 3.06219837 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.03443690 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 3.01980407 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.01158197 |
| 33 | Mitral stenosis (HP:0001718) | 3.00009604 |
| 34 | Anterior segment dysgenesis (HP:0007700) | 2.99428778 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93985427 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.92987576 |
| 37 | Attenuation of retinal blood vessels (HP:0007843) | 2.92560701 |
| 38 | Hyperammonemia (HP:0001987) | 2.90864836 |
| 39 | Nasal polyposis (HP:0100582) | 2.90788918 |
| 40 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.89054152 |
| 41 | Absent/shortened dynein arms (HP:0200106) | 2.89054152 |
| 42 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.87624000 |
| 43 | Myocardial infarction (HP:0001658) | 2.87460495 |
| 44 | Vascular calcification (HP:0004934) | 2.81335591 |
| 45 | Tubular atrophy (HP:0000092) | 2.80737573 |
| 46 | Fat malabsorption (HP:0002630) | 2.77885037 |
| 47 | Hypobetalipoproteinemia (HP:0003563) | 2.77229922 |
| 48 | Broad-based gait (HP:0002136) | 2.69485043 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64858557 |
| 50 | Bundle branch block (HP:0011710) | 2.64043270 |
| 51 | Increased cerebral lipofuscin (HP:0011813) | 2.63977114 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.59562888 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.58827168 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.57640144 |
| 55 | Gait imbalance (HP:0002141) | 2.57601006 |
| 56 | Amyloidosis (HP:0011034) | 2.57246219 |
| 57 | Congenital primary aphakia (HP:0007707) | 2.56409502 |
| 58 | Rhinitis (HP:0012384) | 2.56193407 |
| 59 | Loss of speech (HP:0002371) | 2.55005241 |
| 60 | Bile duct proliferation (HP:0001408) | 2.54757112 |
| 61 | Abnormal biliary tract physiology (HP:0012439) | 2.54757112 |
| 62 | Cystic liver disease (HP:0006706) | 2.53649586 |
| 63 | Polydipsia (HP:0001959) | 2.51729842 |
| 64 | Abnormal drinking behavior (HP:0030082) | 2.51729842 |
| 65 | Sensorimotor neuropathy (HP:0007141) | 2.48978002 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.48959738 |
| 67 | Renal cortical cysts (HP:0000803) | 2.47778838 |
| 68 | Spastic tetraparesis (HP:0001285) | 2.47510147 |
| 69 | Adactyly (HP:0009776) | 2.45504319 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43891224 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.43707601 |
| 72 | Abnormality of macular pigmentation (HP:0008002) | 2.43507466 |
| 73 | Duplicated collecting system (HP:0000081) | 2.42010418 |
| 74 | Abnormality of the renal collecting system (HP:0004742) | 2.39459258 |
| 75 | Hypoalphalipoproteinemia (HP:0003233) | 2.38662669 |
| 76 | Methylmalonic acidemia (HP:0002912) | 2.38659203 |
| 77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.38021442 |
| 78 | Prostate neoplasm (HP:0100787) | 2.37878481 |
| 79 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.37313584 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.37041543 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.37041543 |
| 82 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.35934610 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35451521 |
| 84 | Lissencephaly (HP:0001339) | 2.33233763 |
| 85 | Decreased central vision (HP:0007663) | 2.33066249 |
| 86 | Severe muscular hypotonia (HP:0006829) | 2.32063199 |
| 87 | Methylmalonic aciduria (HP:0012120) | 2.31238802 |
| 88 | Buphthalmos (HP:0000557) | 2.30673035 |
| 89 | Febrile seizures (HP:0002373) | 2.30513305 |
| 90 | Congenital hepatic fibrosis (HP:0002612) | 2.30357009 |
| 91 | Hypothermia (HP:0002045) | 2.30137166 |
| 92 | Axonal loss (HP:0003447) | 2.28733856 |
| 93 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.27930820 |
| 94 | Abnormality of methionine metabolism (HP:0010901) | 2.27476928 |
| 95 | Hypolipoproteinemia (HP:0010981) | 2.27393554 |
| 96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.26833340 |
| 97 | Abnormality of glycine metabolism (HP:0010895) | 2.26833340 |
| 98 | Hypercholesterolemia (HP:0003124) | 2.26716453 |
| 99 | Increased corneal curvature (HP:0100692) | 2.24035930 |
| 100 | Keratoconus (HP:0000563) | 2.24035930 |
| 101 | Ketoacidosis (HP:0001993) | 2.23638629 |
| 102 | Sclerocornea (HP:0000647) | 2.23510654 |
| 103 | Chronic otitis media (HP:0000389) | 2.23053204 |
| 104 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.22511031 |
| 105 | Stomach cancer (HP:0012126) | 2.21709674 |
| 106 | Recurrent sinusitis (HP:0011108) | 2.21403924 |
| 107 | Glomerulonephritis (HP:0000099) | 2.18271631 |
| 108 | Genital tract atresia (HP:0001827) | 2.17237426 |
| 109 | Pulmonary embolism (HP:0002204) | 2.16987775 |
| 110 | Spontaneous abortion (HP:0005268) | 2.16159009 |
| 111 | Hyperglycinemia (HP:0002154) | 2.15523721 |
| 112 | Pendular nystagmus (HP:0012043) | 2.15469018 |
| 113 | Hemiparesis (HP:0001269) | 2.15424084 |
| 114 | Progressive cerebellar ataxia (HP:0002073) | 2.15070461 |
| 115 | Agammaglobulinemia (HP:0004432) | 2.15031407 |
| 116 | Anencephaly (HP:0002323) | 2.12453658 |
| 117 | Gingival bleeding (HP:0000225) | 2.11774737 |
| 118 | Slow saccadic eye movements (HP:0000514) | 2.11660286 |
| 119 | Type II lissencephaly (HP:0007260) | 2.11196460 |
| 120 | Steatorrhea (HP:0002570) | 2.10799698 |
| 121 | Abnormality of the intrinsic pathway (HP:0010989) | 2.09963377 |
| 122 | Focal motor seizures (HP:0011153) | 2.08686501 |
| 123 | Abnormal ciliary motility (HP:0012262) | 2.07396444 |
| 124 | Vaginal atresia (HP:0000148) | 2.06108389 |
| 125 | Mucopolysacchariduria (HP:0008155) | 2.05983735 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05983735 |
| 127 | Cellulitis (HP:0100658) | 2.05191635 |
| 128 | Menorrhagia (HP:0000132) | 2.03877645 |
| 129 | Inability to walk (HP:0002540) | 2.03656523 |
| 130 | Gout (HP:0001997) | 2.03411479 |
| 131 | Tubulointerstitial nephritis (HP:0001970) | 2.02103973 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 2.01471396 |
| 133 | Chronic sinusitis (HP:0011109) | 2.00493366 |
| 134 | Polyuria (HP:0000103) | 2.00458799 |
| 135 | Widely spaced teeth (HP:0000687) | 1.99675433 |
| 136 | Cerebellar dysplasia (HP:0007033) | 1.99654586 |
| 137 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.98742011 |
| 138 | Nephritis (HP:0000123) | 1.98163721 |
| 139 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97443996 |
| 140 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97443996 |
| 141 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.97024981 |
| 142 | Postaxial foot polydactyly (HP:0001830) | 1.96595889 |
| 143 | Intestinal atresia (HP:0011100) | 1.96450953 |
| 144 | Tubulointerstitial fibrosis (HP:0005576) | 1.95822746 |
| 145 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.95800585 |
| 146 | Progressive inability to walk (HP:0002505) | 1.95201077 |
| 147 | Paraparesis (HP:0002385) | 1.92931724 |
| 148 | Polymicrogyria (HP:0002126) | 1.92773818 |
| 149 | Increased CSF lactate (HP:0002490) | 1.92478295 |
| 150 | Absent speech (HP:0001344) | 1.91570920 |
| 151 | Furrowed tongue (HP:0000221) | 1.91062707 |
| 152 | Impaired platelet aggregation (HP:0003540) | 1.90772080 |
| 153 | Abnormal platelet function (HP:0011869) | 1.90772080 |
| 154 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.90059281 |
| 155 | Tubulointerstitial abnormality (HP:0001969) | 1.89053765 |
| 156 | Supranuclear gaze palsy (HP:0000605) | 1.88376633 |
| 157 | Hypoplastic pelvis (HP:0008839) | 1.87996090 |
| 158 | Occipital encephalocele (HP:0002085) | 1.87605509 |
| 159 | Postaxial hand polydactyly (HP:0001162) | 1.86899760 |
| 160 | Congenital sensorineural hearing impairment (HP:0008527) | 1.86650148 |
| 161 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85532147 |
| 162 | Abnormality of alanine metabolism (HP:0010916) | 1.85532147 |
| 163 | Hyperalaninemia (HP:0003348) | 1.85532147 |
| 164 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.85071599 |
| 165 | Astigmatism (HP:0000483) | 1.83956785 |
| 166 | Abnormality of saccadic eye movements (HP:0000570) | 1.83432244 |
| 167 | Male pseudohermaphroditism (HP:0000037) | 1.83364429 |
| 168 | Fair hair (HP:0002286) | 1.83118007 |
| 169 | Focal seizures (HP:0007359) | 1.83007562 |
| 170 | Abnormality of macrophages (HP:0004311) | 1.82386665 |
| 171 | Acute necrotizing encephalopathy (HP:0006965) | 1.82358233 |
| 172 | Retinitis pigmentosa (HP:0000510) | 1.81790399 |
| 173 | Clubbing of toes (HP:0100760) | 1.81202727 |
| 174 | Recurrent bronchitis (HP:0002837) | 1.81200116 |
| 175 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81197118 |
| 176 | Progressive macrocephaly (HP:0004481) | 1.80763489 |
| 177 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.80420611 |
| 178 | Pachygyria (HP:0001302) | 1.80372975 |
| 179 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.80145099 |
| 180 | Hypoplasia of the fovea (HP:0007750) | 1.80145099 |
| 181 | Abnormality of nucleobase metabolism (HP:0010932) | 1.80122656 |
| 182 | Abnormality of purine metabolism (HP:0004352) | 1.79973678 |
| 183 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79199803 |
| 184 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79199803 |
| 185 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79199803 |
| 186 | Confusion (HP:0001289) | 1.78628880 |
| 187 | Abnormality of the labia minora (HP:0012880) | 1.78383681 |
| 188 | Brushfield spots (HP:0001088) | 1.77455911 |
| 189 | Abnormality of the fovea (HP:0000493) | 1.73454605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK2 | 5.70374484 |
| 2 | PIK3CG | 5.08362525 |
| 3 | MAP4K1 | 3.49492995 |
| 4 | MKNK1 | 3.35717365 |
| 5 | MAP3K14 | 3.18647347 |
| 6 | MAP4K2 | 3.13588503 |
| 7 | MAP3K13 | 2.83622386 |
| 8 | WNK3 | 2.83134835 |
| 9 | BMPR1B | 2.73850211 |
| 10 | ADRBK2 | 2.67919063 |
| 11 | RIPK4 | 2.43640797 |
| 12 | TRIM28 | 2.27174887 |
| 13 | MAP3K10 | 2.23922787 |
| 14 | TRIB3 | 2.22865534 |
| 15 | NUAK1 | 2.21445785 |
| 16 | PDK3 | 2.06650815 |
| 17 | PDK4 | 2.06650815 |
| 18 | EPHB1 | 1.99420860 |
| 19 | MAP3K4 | 1.98553170 |
| 20 | ZAK | 1.95041851 |
| 21 | CSF1R | 1.92440602 |
| 22 | ACVR1B | 1.90655168 |
| 23 | SIK1 | 1.89162393 |
| 24 | CASK | 1.88294778 |
| 25 | GRK1 | 1.86787929 |
| 26 | TAOK1 | 1.76163339 |
| 27 | BCKDK | 1.75613605 |
| 28 | MAPK13 | 1.71218962 |
| 29 | SIK2 | 1.70976904 |
| 30 | BLK | 1.68282528 |
| 31 | MUSK | 1.65590202 |
| 32 | EPHA4 | 1.62571145 |
| 33 | KIT | 1.62090119 |
| 34 | BCR | 1.54877406 |
| 35 | PTK2B | 1.45801819 |
| 36 | TNIK | 1.42653810 |
| 37 | PKN1 | 1.29697567 |
| 38 | MAP2K7 | 1.28940291 |
| 39 | GRK6 | 1.28367893 |
| 40 | PAK3 | 1.21877351 |
| 41 | JAK1 | 1.18016712 |
| 42 | DYRK1A | 1.16781943 |
| 43 | PLK2 | 1.16260084 |
| 44 | PRKCQ | 1.16224495 |
| 45 | FGFR4 | 1.12643654 |
| 46 | MARK1 | 1.10498488 |
| 47 | PDK2 | 1.09454166 |
| 48 | TYK2 | 1.09289666 |
| 49 | TXK | 1.07673934 |
| 50 | TAOK2 | 1.07609127 |
| 51 | MAP3K11 | 1.06524340 |
| 52 | MST4 | 1.04521739 |
| 53 | TBK1 | 1.03306297 |
| 54 | ERN1 | 1.02868850 |
| 55 | MAP2K2 | 1.02180506 |
| 56 | SYK | 0.99804367 |
| 57 | HCK | 0.99292440 |
| 58 | EIF2AK3 | 0.98610890 |
| 59 | CSK | 0.98264989 |
| 60 | STK39 | 0.97647292 |
| 61 | FES | 0.97401446 |
| 62 | PRKCH | 0.95956080 |
| 63 | TGFBR2 | 0.95419434 |
| 64 | MAP3K3 | 0.95069522 |
| 65 | PKN2 | 0.94427511 |
| 66 | PDK1 | 0.93937427 |
| 67 | PRKCE | 0.93799489 |
| 68 | ERBB3 | 0.92132838 |
| 69 | OXSR1 | 0.91295389 |
| 70 | LRRK2 | 0.90401448 |
| 71 | IRAK3 | 0.87873803 |
| 72 | ADRBK1 | 0.87495198 |
| 73 | FGFR2 | 0.87375266 |
| 74 | RET | 0.86450720 |
| 75 | PNCK | 0.84426599 |
| 76 | CAMK1G | 0.83304716 |
| 77 | CSNK1G2 | 0.81437337 |
| 78 | STK11 | 0.80259521 |
| 79 | FYN | 0.80244900 |
| 80 | TEC | 0.78730414 |
| 81 | PINK1 | 0.78291720 |
| 82 | DAPK2 | 0.77892047 |
| 83 | PTK6 | 0.77380716 |
| 84 | FER | 0.77133403 |
| 85 | KSR2 | 0.77033319 |
| 86 | CSNK1G1 | 0.76450757 |
| 87 | NTRK3 | 0.75911098 |
| 88 | MAP3K9 | 0.74382693 |
| 89 | TLK1 | 0.73657195 |
| 90 | MAP3K2 | 0.73302189 |
| 91 | MATK | 0.73133743 |
| 92 | MAP2K4 | 0.72555180 |
| 93 | PIK3CA | 0.72362587 |
| 94 | MAPK4 | 0.72314487 |
| 95 | MARK3 | 0.70971410 |
| 96 | IKBKB | 0.70943877 |
| 97 | FGR | 0.70427602 |
| 98 | PRKCG | 0.70011230 |
| 99 | PRKD1 | 0.69582936 |
| 100 | DYRK2 | 0.69582748 |
| 101 | CSNK1G3 | 0.69203839 |
| 102 | JAK2 | 0.68343051 |
| 103 | TNK2 | 0.66517483 |
| 104 | PDPK1 | 0.65191425 |
| 105 | LCK | 0.64576089 |
| 106 | BMX | 0.64443971 |
| 107 | STK38L | 0.63766593 |
| 108 | IKBKE | 0.63630111 |
| 109 | IRAK1 | 0.63377162 |
| 110 | AKT3 | 0.63087633 |
| 111 | MAP3K5 | 0.62935189 |
| 112 | BTK | 0.62862303 |
| 113 | JAK3 | 0.62608035 |
| 114 | ROCK2 | 0.61846016 |
| 115 | FRK | 0.60967825 |
| 116 | INSRR | 0.60879554 |
| 117 | CAMKK2 | 0.59976433 |
| 118 | CSNK1A1L | 0.59893899 |
| 119 | SGK3 | 0.59559865 |
| 120 | MAPK7 | 0.56904654 |
| 121 | PLK3 | 0.56854289 |
| 122 | STK10 | 0.56364314 |
| 123 | TGFBR1 | 0.55236985 |
| 124 | TAOK3 | 0.55132614 |
| 125 | GSK3A | 0.54751677 |
| 126 | WNK1 | 0.54686332 |
| 127 | CCNB1 | 0.54541385 |
| 128 | PAK6 | 0.53976895 |
| 129 | SGK223 | 0.52257082 |
| 130 | SGK494 | 0.52257082 |
| 131 | ABL2 | 0.52207394 |
| 132 | GRK7 | 0.50651240 |
| 133 | ITK | 0.50509821 |
| 134 | PDGFRB | 0.50094758 |
| 135 | FLT3 | 0.49966659 |
| 136 | TTN | 0.49656976 |
| 137 | STK24 | 0.49362252 |
| 138 | CLK1 | 0.48902801 |
| 139 | WNK4 | 0.48858649 |
| 140 | MAPK12 | 0.47890253 |
| 141 | PRKCZ | 0.47093797 |
| 142 | MAP3K7 | 0.46799806 |
| 143 | ABL1 | 0.46728686 |
| 144 | CAMK2A | 0.46304325 |
| 145 | MAP2K3 | 0.45550555 |
| 146 | CHEK2 | 0.44037694 |
| 147 | SRPK1 | 0.43624964 |
| 148 | STK3 | 0.42545450 |
| 149 | LYN | 0.41990418 |
| 150 | VRK1 | 0.41526957 |
| 151 | PRKACG | 0.41481186 |
| 152 | CSNK1A1 | 0.40919366 |
| 153 | DYRK1B | 0.40651806 |
| 154 | SIK3 | 0.39862413 |
| 155 | KSR1 | 0.39803152 |
| 156 | IGF1R | 0.39237405 |
| 157 | ALK | 0.38659432 |
| 158 | GRK5 | 0.37769901 |
| 159 | WEE1 | 0.37661281 |
| 160 | TIE1 | 0.37589735 |
| 161 | SGK1 | 0.37511337 |
| 162 | TRPM7 | 0.36730539 |
| 163 | PRKAA2 | 0.36720577 |
| 164 | EPHA3 | 0.35924377 |
| 165 | PRKACA | 0.35083906 |
| 166 | PLK4 | 0.34412871 |
| 167 | BRSK2 | 0.34067689 |
| 168 | DYRK3 | 0.31976720 |
| 169 | MAP3K12 | 0.29589720 |
| 170 | NLK | 0.29476000 |
| 171 | CAMK1 | 0.29069236 |
| 172 | MINK1 | 0.28128650 |
| 173 | MAP2K6 | 0.27724194 |
| 174 | BMPR2 | 0.27158349 |
| 175 | PLK1 | 0.26182790 |
| 176 | CSNK1D | 0.25904308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.73976100 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.62361644 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.34483294 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.63501760 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.34382217 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26283666 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.22140955 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.19819739 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18394584 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09899394 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.08502565 |
| 12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.05760304 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98362864 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.98309871 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.95969262 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93540319 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.91175827 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90753397 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.80849957 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.80207839 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.78833366 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.78665035 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75993631 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.70443228 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68310147 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67275398 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.66072154 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64416139 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62731237 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.61447692 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61034391 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.56832840 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.53897786 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52783031 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.52496067 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52243870 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.49026560 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48212744 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.48072435 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46877940 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44308577 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39531180 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38633187 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35625535 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29297891 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26041910 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24533049 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24397661 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 1.22204391 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17759477 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10074056 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08608977 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08203685 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07600375 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05234954 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.05113720 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.04838382 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04690149 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04360235 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00472391 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99741305 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96336207 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92125547 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91638289 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.90501422 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90482495 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.90199360 |
| 68 | Circadian entrainment_Homo sapiens_hsa04713 | 0.89690721 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88081916 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84856691 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84558550 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.83847834 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82317283 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80976164 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80635313 |
| 76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79694898 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76909761 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76453124 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75961889 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75190569 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73883013 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71659540 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65634543 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63936084 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63000347 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62031763 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.61285081 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60300987 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59044447 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.58721541 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58631815 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58377553 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58304080 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58194120 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.57288461 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56640805 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54134210 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54053065 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53207070 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.51671592 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49755365 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49408460 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48064915 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.46052724 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46005861 |
| 106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45552852 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45243189 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44123340 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44085101 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41804618 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41461023 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41335968 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41029989 |
| 114 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40918071 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40341034 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39668458 |
| 117 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38321923 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37615358 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.36987936 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36802595 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35374654 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.34949975 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34734701 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33022680 |
| 125 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32984075 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32432453 |
| 127 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32137841 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.32027419 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.31859545 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.31644126 |
| 131 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31621049 |
| 132 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31515647 |
| 133 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31209214 |
| 134 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31113467 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30689871 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30623723 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30185079 |
| 138 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30135396 |
| 139 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29961614 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29600608 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.29492420 |
| 142 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.29421328 |
| 143 | Pertussis_Homo sapiens_hsa05133 | 0.29034045 |
| 144 | Glioma_Homo sapiens_hsa05214 | 0.28636515 |
| 145 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28514180 |
| 146 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28453230 |
| 147 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.27995386 |
| 148 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27606145 |
| 149 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27565353 |
| 150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26649119 |
| 151 | Salivary secretion_Homo sapiens_hsa04970 | 0.26575460 |
| 152 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26243302 |
| 153 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25549164 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25127438 |
| 155 | Platelet activation_Homo sapiens_hsa04611 | 0.25031805 |
| 156 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.24117636 |
| 157 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21627567 |
| 158 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.21503380 |
| 159 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.21309531 |

